Liontrust Investment Partners’s Pfizer PFE Stock Holding History

Liontrust Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-140,316	Closed	-$5.15M	–	218
2023 Q2	$5.15M	Sell	140,316 -317,761	-69%	-$12.4M	0.07%	132
2023 Q1	$18.7M	Sell	458,077 -116,923	-20%	-$5.05M	0.27%	64
2022 Q4	$29.5M	Sell	575,000 -115,927	-17%	-$5.56M	0.51%	40
2022 Q3	$30.2M	Sell	690,927 -187,285	-21%	-$9.1M	0.48%	39
2022 Q2	$46M	Buy	878,212 +208,212	+31%	+$10.6M	0.65%	35
2022 Q1	$35.2M	Buy	670,000 +10,000	+2%	+$519K	0.46%	37
2021 Q4	$39M	Sell	660,000 -72,350	-10%	-$3.58M	0.46%	37
2021 Q3	$31.5M	Buy	+732,350	New	+$32.4M	0.44%	40
2020 Q4	$602K	Buy	+16,350	New	+$600K	0.01%	206

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Liontrust Investment Partners's PFE Position: Q3 2023 in Review

Liontrust Investment Partners sold out of Pfizer (PFE) in Q3 2023, closing a stake of 140,316 shares — an estimated $5.15M sold.

Liontrust Investment Partners first reported a position in PFE in Q4 2020 and held it in 9 quarters. The position peaked at $46M in Q2 2022. 2,925 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Liontrust Investment Partners reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Liontrust Investment Partners sold 140,316 Pfizer shares in Q3 2023, an estimated $5.15M.
Liontrust Investment Partners first reported a position in Pfizer in Q4 2020 and held it in 9 quarters.
Liontrust Investment Partners's Pfizer position peaked at $46M in Q2 2022.
2,925 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Liontrust Investment Partners's 13F filing for Q3 2023, filed 9 Nov 2023.